Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
70.86 USD | +0.70% | -1.88% | -0.43% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.43% | 1.26B | |
+25.93% | 653B | |
+27.00% | 556B | |
-6.61% | 354B | |
+20.48% | 331B | |
+2.82% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-5.88% | 144B |
- Stock Market
- Equities
- LGND Stock
- News Ligand Pharmaceuticals Incorporated
- Ligand Pharmaceuticals Incorporated : and GSK Sign License Agreement to Target Neurological Disorders Based on Icagen's Technology